PROCTER & GAMBLE HEALTH
Back to Cashflow Statement
|
PROCTER & GAMBLE HEALTH Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Jun2024 | Jun2023 | Jun2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-344 Cr | ₹-235 Cr | ₹-418 Cr | ₹-98 Cr | ₹-289 Cr |
What is the latest Cash Flow from Financing Activities ratio of PROCTER & GAMBLE HEALTH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-344 Cr |
| Mar2025 | ₹-235 Cr |
| Jun2024 | ₹-418 Cr |
| Jun2023 | ₹-98 Cr |
| Jun2022 | ₹-289 Cr |
How is Cash Flow from Financing Activities of PROCTER & GAMBLE HEALTH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-344 Cr | Negative | |
| Mar2025 | ₹-235 Cr | Negative | |
| Jun2024 | ₹-418 Cr | Negative | |
| Jun2023 | ₹-98 Cr | Negative | |
| Jun2022 | ₹-289 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PROCTER & GAMBLE HEALTH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PROCTER & GAMBLE HEALTH | ₹9,147.6 Cr | 9.5% | 1.9% | -11.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
PROCTER & GAMBLE HEALTH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PROCTER & GAMBLE HEALTH | 9.5% |
1.9% |
-11.6% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses